Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment. - Wikidata - awgldk - TriplyDB

Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment.

Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment.

http://www.wikidata.org/entity/Q50726972

about

Withdrawal or continuation of cholinesterase inhibitors and/or memantine in patients with dementia Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease.Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease: Cross-Talk with P-tau and β-Amyloid Galanthamine plus estradiol treatment enhances cognitive performance in aged ovariectomized rats.Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application.Donepezil: an update.Influence of rs1080985 single nucleotide polymorphism of the CYP2D6 gene on response to treatment with donepezil in patients with alzheimer's disease.Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs.Acute but not chronic donepezil increases muscarinic receptor-mediated signaling via arachidonic acid in unanesthetized rats.Concentration of Donepezil in the Cerebrospinal Fluid of AD Patients: Evaluation of Dosage Sufficiency in Standard Treatment Strategy Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease.Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases.Fibrillar β-amyloid 1-42 alters cytokine secretion, cholinergic signalling and neuronal differentiation.Effects of Mimosa pudica L. leaves extract on anxiety, depression and memory.Therapeutic dosage assessment based on population pharmacokinetics of a novel single-dose transdermal donepezil patch in healthy volunteers.Anti-Parkinson Drug Biperiden Inhibits Enzyme Acetylcholinesterase.Increasing hippocampal acetylcholine levels enhance behavioral performance in an animal model of diencephalic amnesia.Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System.Increased dosage of donepezil for the management of behavioural and psychological symptoms of dementia in dementia with Lewy bodies.Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease.

P2860

Q24235324-5AD720D3-6022-4D6B-9433-4C30C5983F0C Q33586027-F6334B3D-F977-40B4-BA4A-07F007E5AF3D Q33715239-0FF75208-DAD7-4871-8732-CDDDB7876018 Q35210180-CF58A1F3-DD2F-46CE-A4A7-6D8B09B70D08 Q35534146-F616B7C9-5D35-40E4-8811-443B8DA99736 Q36632702-D05A18DF-8591-48E4-84D2-EE3DFF70F36F Q36808057-CEAD89BC-628D-4CAD-AEDF-9B3FE9B0CE0A Q37092283-72841735-E7E1-46F2-9D0B-C05BFE6533B0 Q37104891-1B241036-9014-4210-B767-A3E73A2B8685 Q37464280-AA085577-4321-490B-A407-0935518580B7 Q37553489-2B860C2A-7E0B-4006-A18D-498ADCE4A37A Q38208461-EBACC8FF-17E5-4545-99EB-C147885950E2 Q38289739-AFE68958-0E66-4B63-ABC8-01C39EB7A979 Q38967438-5F107E24-1DA9-4E68-BEE7-5AE4DBE6AE1A Q40553725-FE3F8942-9B36-4D8F-8717-EF0679529C4A Q40899039-7F434A52-A024-4B49-AB20-F9B9B758A2EA Q41146736-E0F9282A-2B59-4209-A6BF-BB22C66DFCA2 Q41886983-DC455C4C-7407-43DE-8CF0-08A324088DD2 Q49721453-45F83F07-A623-4114-84BC-0135B111E6C6 Q50954269-55D6583B-B6C6-4C31-8EF8-6B4D437EAED7 Q53313228-27D0CEB3-F954-4D7E-8D27-603C50AC3EBC

P2860

Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment.

http://www.wikidata.org/entity/Q50726972

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Changes in the activity and pr ...... g chronic donepezil treatment.

@en

Changes in the activity and pr ...... g chronic donepezil treatment.

@nl

type

label

Changes in the activity and pr ...... g chronic donepezil treatment.

@en

Changes in the activity and pr ...... g chronic donepezil treatment.

@nl

prefLabel

Changes in the activity and pr ...... g chronic donepezil treatment.

@en

Changes in the activity and pr ...... g chronic donepezil treatment.

@nl

P1433

Q50726972-F5B4DD92-A7CF-4A0C-8E69-0BB19EE0CBB2

P1476

Q50726972-119C648B-0272-44BE-8EDB-6C6B86D37967

P2093

Q50726972-02579749-B12D-43F2-8A50-65FE4AEA85D0

Q50726972-3EABAA4E-4601-4175-A64A-6CFC692180BD

Q50726972-668699A1-C464-4C5F-9F24-4B08EC3E6761

Q50726972-7EE251D9-2A93-4F87-A335-18D258C12977

Q50726972-D41BE212-4565-4097-969C-612AB2996059

P2860

Q50726972-7A434EC4-B702-476D-BB38-17F79E574424

Q50726972-B9BF49EF-240C-4F0D-A3DB-2C0E9A10B501

P2888

Q50726972-5DBDE84E-B2CA-4A71-B73F-F7455FDB84E2

P304

Q50726972-470CAD9C-F96E-418E-8EDA-DA7C8A2A7A8D

P31

Q50726972-EBBCDEA7-B5CB-4D99-9AEB-70732E416591

P356

Q50726972-1F22ED61-F52F-4F31-BED9-F83CACD99439

P433

Q50726972-D891B8E3-B87E-457F-B5F5-937552C2EFC3

P478

Q50726972-A6A7B72E-AE13-4526-B507-00055452D0D0

P50

Q50726972-553D4D0C-C763-42EE-9BB7-F59040DB270F

Q50726972-7CD418B3-434F-4281-9685-DBF467237238

Q50726972-83AFC985-AE9B-4862-90AF-9BDB3CA6A98E

P577

Q50726972-4CFBCD41-A849-4BAF-B22A-632CE6A8878E

P5875

Q50726972-8B8340C1-CA87-4153-BCC3-100A4A47E437

P698

Q50726972-F8AA14A6-F523-4DFB-90CD-5CBAAE4D4079

P356

S00702-006-0526-2

P1433

Journal of Neural Transmission

P1476

Changes in the activity and pr ...... ng chronic donepezil treatment

@en

P2093

E Hellström-Lindahl

http://www.w3.org/2001/XMLSchema#string

K Hugosson

http://www.w3.org/2001/XMLSchema#string

L Meurling

http://www.w3.org/2001/XMLSchema#string

N Andreasen

http://www.w3.org/2001/XMLSchema#string

T Pettersson

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.

P2888

s00702-006-0526-2

P304

1791-1801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00702-006-0526-2

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Taher Darreh-Shori

Agneta Nordberg

Lennart Minthon

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6917156

http://www.w3.org/2001/XMLSchema#string

P698

16868793

http://www.w3.org/2001/XMLSchema#string